This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Inhibitors
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='2f1o.pdb' size='350' frame='true' side='right' scene='2f1o/Com_view/2' caption='NADPH dehydrogenase complex with FAD and inhibitor dicoumarol 2f1o'> This is a ...) |
|||
| Line 1: | Line 1: | ||
<StructureSection load='2f1o.pdb' size='350' frame='true' side='right' scene='2f1o/Com_view/2' caption='NADPH dehydrogenase complex with FAD and inhibitor dicoumarol [[2f1o]]'> | <StructureSection load='2f1o.pdb' size='350' frame='true' side='right' scene='2f1o/Com_view/2' caption='NADPH dehydrogenase complex with FAD and inhibitor dicoumarol [[2f1o]]'> | ||
| - | + | *[[AChE inhibitors and substrates]] | |
| - | + | *[[Drug Metabolism by CYP450 Enzymes]] | |
| - | + | *In a ''substrate reduction therapy'' a small molecule inhibitor ([[Acid beta-glucosidase with N-nonyl-deoxynojirimycin|Zavesca™]]) is used to inhibit the synthesis of the accumulated glucosylceramide. | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:16, 17 October 2021
| |||||||||||
